Tribunal Awaits Judge's Nod On Daiichi Drug Patent Fight
An arbitrator weighing whether he can adjudicate biotechnology company Seattle Genetics Inc.'s dispute with Daiichi Sankyo Co. Ltd. over cancer drug patents will wait for recommendations from a Delaware court before...To view the full article, register now.
Already a subscriber? Click here to view full article